← Leaderboards
Guillermina Lozano
University Of Tx Md Anderson Can Ctr
$24,537,407
Attributed
$24,537,407
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,537,407 · 11
By mechanism
R01$15,621,900 · 3
T32$3,970,796 · 1
P30$2,434,574 · 2
P01$1,925,445 · 3
R21$382,800 · 1
S10$201,892 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Junjie Chen$28,940,212
- Wenyi Wang$5,065,820
- Veerabhadran Baladandayuthapani$6,303,874
- Rachel Katherine Miller$2,839,337
- Shiaw-Yih Lin$9,839,199
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorMutationMalignant NeoplasmsIn VivoProgramsTumorigenesisTp53 GenePathway InteractionsGenesMouse ModelPhenotypeDefectResponseAllelesMutantProtein P53ApoptosisProteinsCellsDna DamageMolecularGene ExpressionTumor SuppressionRegulation
Grant awards (85)
A Pathway of Tumor Suppression$466,560
R01 · FY2025 · CA · contact PI
A Pathway of Tumor Suppression$443,233
R01 · FY2024 · CA · contact PI
Role of p53 Missense Mutations on Tumorigenesis in Vivo$365,513
R01 · FY2024 · CA · contact PI
A Pathway of Tumor Suppression$466,560
R01 · FY2023 · CA · contact PI
Role of p53 Missense Mutations on Tumorigenesis in Vivo$384,750
R01 · FY2023 · CA · contact PI
A Pathway of Tumor Suppression$466,560
R01 · FY2022 · CA · contact PI
Role of p53 Missense Mutations on Tumorigenesis in Vivo$377,055
R01 · FY2022 · CA · contact PI
The roles of TRIM24 in breast cancer$402,021
R01 · FY2021 · CA · contact PI
Role of p53 Missense Mutations on Tumorigenesis in Vivo$384,750
R01 · FY2021 · CA · contact PI
A Pathway of Tumor Suppression$366,000
R01 · FY2021 · CA · contact PI
03 Genetically Engineered Mouse Facility$487,249
P30 · FY2020 · CA · contact PI
The roles of TRIM24 in breast cancer$402,021
R01 · FY2020 · CA · contact PI
Role of p53 Missense Mutations on Tumorigenesis in Vivo$384,750
R01 · FY2020 · CA · contact PI
A Pathway of Tumor Suppression$366,000
R01 · FY2020 · CA · contact PI
03 Genetically Engineered Mouse Facility$488,083
P30 · FY2019 · CA · contact PI
A Pathway of Tumor Suppression$355,019
R01 · FY2019 · CA · contact PI
Role of p53 Missense Mutations on Tumorigenesis in Vivo$331,739
R01 · FY2019 · CA · contact PI
03 Genetically Engineered Mouse Facility$5,456
P30 · FY2019 · CA · contact PI
A Pathway of Tumor Suppression$366,000
R01 · FY2018 · CA · contact PI
Role of p53 Missense Mutations on Tumorigenesis in Vivo$342,000
R01 · FY2018 · CA · contact PI
Upgrading an existing NIKON A1-confocal with LUNV Laser Launch and DU-G detector$201,892
S10 · FY2018 · OD · contact PI
A Pathway of Tumor Suppression$366,000
R01 · FY2017 · CA · contact PI
Role of p53 Missense Mutations on Tumorigenesis in Vivo$342,000
R01 · FY2017 · CA · contact PI
(PQ4) Mutations in the histone chaperone DAXX drive pancreatic neuroendocrine tumors not ductal adenocarcinomas$174,000
R21 · FY2017 · CA · contact PI
Role of p53 Missense Mutations on Tumorigenesis in Vivo$342,000
R01 · FY2016 · CA · contact PI
A Pathway of Tumor Suppression$249,580
R01 · FY2016 · CA · contact PI
(PQ4) Mutations in the histone chaperone DAXX drive pancreatic neuroendocrine tumors not ductal adenocarcinomas$208,800
R21 · FY2016 · CA · contact PI
Role of p53 Missense Mutations on Tumorigenesis in Vivo$342,000
R01 · FY2015 · CA · contact PI
A Pathway of Tumor Suppression$249,580
R01 · FY2015 · CA · contact PI
Training Program in Molecular Genetics of Cancer$423,057
T32 · FY2014 · CA · contact PI
Role of p53 Missense Mutations on Tumorigenesis in Vivo$294,005
R01 · FY2014 · CA · contact PI
A Pathway of Tumor Suppression$242,092
R01 · FY2014 · CA · contact PI
Training Program in Molecular Genetics of Cancer$338,656
T32 · FY2013 · CA · contact PI
Role of p53 Missense Mutations on Tumorigenesis in Vivo$284,912
R01 · FY2013 · CA · contact PI
A Pathway of Tumor Suppression$234,605
R01 · FY2013 · CA · contact PI
Training Program in Molecular Genetics of Cancer$419,354
T32 · FY2012 · CA · contact PI
Role of p53 Missense Mutations on Tumorigenesis in Vivo$303,098
R01 · FY2012 · CA · contact PI
Genomics Facility$299,510
P30 · FY2012 · CA · contact PI
A Pathway of Tumor Suppression$249,580
R01 · FY2012 · CA · contact PI
Genomics Facility$2,882
P30 · FY2012 · CA · contact PI
Training Program in Molecular Genetics of Cancer$395,907
T32 · FY2011 · CA · contact PI
Genomics Facility$306,262
P30 · FY2011 · CA · contact PI
Role of p53 Missense Mutations on Tumorigenesis in Vivo$303,098
R01 · FY2011 · CA · contact PI
Training Program in Molecular Genetics of Cancer$411,822
T32 · FY2010 · CA · contact PI
Mouse Models for Li Fraumeni Syndrome$329,789
P01 · FY2010 · CA · contact PI
Genomics Facility$319,371
P30 · FY2010 · CA · contact PI
A Pathway of Tumor Suppression$236,943
R01 · FY2010 · CA · contact PI
Role of p53 Missense Mutations on Tumorigenesis in Vivo$138,877
R01 · FY2010 · CA · contact PI
Mouse Models for Li Fraumeni Syndrome$324,736
P01 · FY2009 · CA · contact PI
Genomics Facility$321,694
P30 · FY2009 · CA · contact PI
Role of p53 Missense Mutations on Tumorigenesis in Vivo$256,010
R01 · FY2009 · CA · contact PI
A Pathway of Tumor Suppression$236,943
R01 · FY2009 · CA · contact PI
Mouse Models for Li Fraumeni Syndrome$315,131
P01 · FY2008 · CA · contact PI
Role of p53 Missense Mutations on Tumorigenesis in Vivo$256,010
R01 · FY2008 · CA · contact PI
Training Program in Molecular Genetics of Cancer$243,513
T32 · FY2008 · CA · contact PI
A Pathway of Tumor Suppression$236,943
R01 · FY2008 · CA · contact PI
Genomics Facility$204,067
P30 · FY2008 · CA · contact PI
Training Program in Molecular Genetics of Cancer$388,954
T32 · FY2007 · CA · contact PI
Mouse Models for Li Fraumeni Syndrome$308,221
P01 · FY2007 · CA · contact PI
Role of p53 Missense Mutations on Tumorigenesis in Vivo$256,010
R01 · FY2007 · CA · contact PI
A Pathway of Tumor Suppression$236,943
R01 · FY2007 · CA · contact PI
Training Program in Molecular Genetics of Cancer$372,885
T32 · FY2006 · CA · contact PI
Role of p53 Missense Mutations on Tumorigenesis in Vivo$263,655
R01 · FY2006 · CA · contact PI
A Pathway of Tumor Suppression$244,020
R01 · FY2006 · CA · contact PI
Mouse Models for Li Fraumeni Syndrome$200,847
P01 · FY2006 · CA · contact PI
Training Program in Molecular Genetics of Cancer$344,403
T32 · FY2005 · CA
Role of p53 Missense Mutations on Tumorigenesis in Vivo$270,000
R01 · FY2005 · CA
A PATHWAY OF TUMOR SUPPRESSION$249,000
R01 · FY2005 · CA
Training Program in Molecular Genetics of Cancer$293,242
T32 · FY2004 · CA
A PATHWAY OF TUMOR SUPPRESSION$249,000
R01 · FY2004 · CA
TRAINING PROGRAM IN MOLECULAR GENETICS OF CANCER$339,003
T32 · FY2003 · CA
P53 MISSENSE MUTATIONS ON TUMORIGENESIS AND VIVO$268,865
R01 · FY2003 · CA
A PATHWAY OF TUMOR SUPPRESSION$249,000
R01 · FY2003 · CA
P53 MISSENSE MUTATIONS ON TUMORIGENESIS AND VIVO$261,032
R01 · FY2002 · CA
A PATHWAY OF TUMOR SUPPRESSION$249,000
R01 · FY2002 · CA
CORE--MUTATION DETECTION &CHARACTERIZATION OF TUMOR SUPPRESSOR GENES$0
P01 · FY2002 · CA
MOLECULAR BASIS OF INHERITED CANCER SYNDROMES$0
P01 · FY2002 · CA
P53 MISSENSE MUTATIONS ON TUMORIGENESIS AND VIVO$253,429
R01 · FY2001 · CA
A PATHWAY OF TUMOR SUPPRESSION$249,000
R01 · FY2001 · CA
CORE--MUTATION DETECTION &CHARACTERIZATION OF TUMOR SUPPRESSOR GENES$0
P01 · FY2001 · CA
MOLECULAR BASIS OF INHERITED CANCER SYNDROMES$0
P01 · FY2001 · CA
MOLECULAR BASIS OF INHERITED CANCER SYNDROMES$270,395
P01 · FY2000 · CA
P53 MISSENSE MUTATIONS ON TUMORIGENESIS AND VIVO$246,048
R01 · FY2000 · CA
PATHWAY OF TUMOR SUPPRESSION$242,091
R01 · FY2000 · CA
CORE--MUTATION DETECTION &CHARACTERIZATION OF TUMOR SUPPRESSOR GENES$176,326
P01 · FY2000 · CA